Sign Up to like & get recommendations! 1
Published in 2017 at "World Journal of Surgery"
DOI: 10.1007/s00268-017-4376-x
Abstract: Dr. Polenta and her colleagues have provided our neuroendocrine surgical community with a very interesting and detailed assessment of the accuracy of preoperative imaging for pancreatic neuroendocrine neoplasms (pNEN) in patients with multiple endocrine neoplasia… read more here.
Sign Up to like & get recommendations! 2
Published in 2017 at "Endocrinology and metabolism clinics of North America"
DOI: 10.1016/j.ecl.2017.01.011
Abstract: Multiple endocrine neoplasia syndromes types 1 and 2 represent well-characterized yet clinically heterogeneous hereditary conditions for which diagnostic and management recommendations exist; genetic testing for these inherited endocrinopathies is included in these guidelines and is… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "International Journal of Surgery Case Reports"
DOI: 10.1016/j.ijscr.2020.07.015
Abstract: Highlights • Every case essential, because MEN 2A is reported in 500–1000 families worldwide.• This case reflects correct clinical steps in avoidance of possible complications.• It contributes to the existing limited literature reports.• MTC can… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Stem cell research"
DOI: 10.1016/j.scr.2016.12.002
Abstract: Urine resource cells were collected from a 23-year-old male with multiple endocrine neoplasia type 1 syndrome (MEN1) for generating iPS cells with episomal plasmids. Two stable iPSC lines with free of episomal plasmid were established.… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Surgery"
DOI: 10.1016/j.surg.2017.08.002
Abstract: Background. Pheochromocytoma and/or paraganglioma associated with neurofibromatosis type 1, multiple endocrine neoplasia type 2A, and von Hippel‐Lindau disease have different catecholamine biochemical phenotypes. We examined perioperative outcomes of pheochromocytoma/paraganglioma resection in 3 syndromic forms. Methods.… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Ophthalmic Genetics"
DOI: 10.1080/13816810.2017.1408849
Abstract: ABSTRACT Background: To describe ocular and vascular findings in a patient with multiple endocrine neoplasia type 2B. Materials and methods: Case report of a 31-year-old male who was referred for ocular assessment following diagnosis of… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "Cornea"
DOI: 10.1097/ico.0000000000002028
Abstract: OBJECTIVE To report a case of a patient affected by multiple endocrine neoplasia type 2B (MEN 2B) with imaging of conjunctival neuromas by in vivo confocal microscopy (IVCM). METHODS Case report. RESULTS A 48-year-old patient… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000004051
Abstract: ABSTRACT A patient with multiple endocrine neoplasia type 2A syndrome who had exhausted several surgeries and radiotherapy was referred to nuclear medicine department for theranostic approaches. [68Ga]-DOTATATE PET/CT and [131I]I-mIBG SPECT/CT were performed, but the… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Clinical Endocrinology"
DOI: 10.1111/cen.13324
Abstract: Pancreatic neuroendocrine tumours (PNETs) are the most common cause of death in patients with multiple endocrine neoplasia type 1 (MEN1). Women have been shown to have improved survival, which may suggest a possible protective effect… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Clinical Endocrinology"
DOI: 10.1111/cen.13386
Abstract: We describe phaeochromocytoma (phaeo) penetrance in multiple endocrine neoplasia type 2 (MEN2) according to RET protooncogene‐specific mutations and report changes in phaeo diagnosis and management from 1968 to 2015. read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Clinical Endocrinology"
DOI: 10.1111/cen.14067
Abstract: Multiple endocrine neoplasia 1 (MEN 1) is an autosomal dominant disease presenting as hyperplasia and neoplasia of parathyroid, pituitary and enteropancreatic tissues. Over 90% of gene carriers develop phenotypic disease by age 30 years, potentially… read more here.